AirSculpt Technologies, Inc. (NASDAQ:AIRS) Short Interest Up 15.2% in November

AirSculpt Technologies, Inc. (NASDAQ:AIRS - Get Free Report) was the recipient of a significant increase in short interest in November. As of November 15th, there was short interest totalling 1,820,000 shares, an increase of 15.2% from the October 31st total of 1,580,000 shares. Approximately 14.9% of the shares of the company are short sold. Based on an average trading volume of 143,600 shares, the short-interest ratio is currently 12.7 days.

AirSculpt Technologies Trading Up 2.9 %

Shares of NASDAQ:AIRS traded up $0.19 on Friday, reaching $6.83. 72,278 shares of the company traded hands, compared to its average volume of 246,064. AirSculpt Technologies has a 52 week low of $2.92 and a 52 week high of $9.20. The stock has a market capitalization of $395.32 million, a P/E ratio of -48.79 and a beta of 1.57. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.80. The business's 50-day simple moving average is $6.10 and its 200 day simple moving average is $4.85.

AirSculpt Technologies (NASDAQ:AIRS - Get Free Report) last posted its quarterly earnings data on Friday, November 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by ($0.05). AirSculpt Technologies had a positive return on equity of 2.22% and a negative net margin of 4.13%. The company had revenue of $42.55 million for the quarter, compared to analyst estimates of $42.49 million. During the same quarter in the prior year, the company posted ($0.01) earnings per share. As a group, equities analysts anticipate that AirSculpt Technologies will post 0.08 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, BTIG Research initiated coverage on AirSculpt Technologies in a report on Thursday, October 17th. They set a "neutral" rating on the stock.

Insiders Place Their Bets

In other AirSculpt Technologies news, CEO Dennis Dean sold 24,510 shares of the company's stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $6.54, for a total value of $160,295.40. Following the transaction, the chief executive officer now directly owns 582,052 shares in the company, valued at $3,806,620.08. This represents a 4.04 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 78.77% of the company's stock.

Institutional Investors Weigh In On AirSculpt Technologies

Institutional investors have recently bought and sold shares of the company. SW Investment Management LLC boosted its stake in AirSculpt Technologies by 5.0% during the 2nd quarter. SW Investment Management LLC now owns 4,500,000 shares of the company's stock worth $18,000,000 after purchasing an additional 213,677 shares during the last quarter. Vanguard Group Inc. boosted its position in AirSculpt Technologies by 1.0% during the first quarter. Vanguard Group Inc. now owns 576,038 shares of the company's stock worth $3,537,000 after acquiring an additional 5,606 shares during the last quarter. Geode Capital Management LLC grew its stake in AirSculpt Technologies by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 355,540 shares of the company's stock valued at $1,803,000 after acquiring an additional 21,339 shares in the last quarter. Finally, Barclays PLC raised its holdings in AirSculpt Technologies by 227.0% in the 3rd quarter. Barclays PLC now owns 19,100 shares of the company's stock valued at $97,000 after acquiring an additional 13,259 shares during the last quarter. 91.54% of the stock is currently owned by institutional investors and hedge funds.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.